Title | Type | SJR | H index | Total Docs. (2023) | Total Docs. (3years) | Total Refs. (2023) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2023) | %Female (2023) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | International Journal of Nanomedicine | journal | 1.273 Q1 | 179 | 443 | 1559 | 33731 | 12840 | 1554 | 6.74 | 76.14 | 43.56 | |
2 | Drug Design, Development and Therapy | journal | 0.999 Q1 | 94 | 271 | 1141 | 13688 | 5855 | 1136 | 4.89 | 50.51 | 45.28 | |
3 | Biomarker Insights | journal | 0.974 Q1 | 40 | 9 | 67 | 468 | 246 | 59 | 3.34 | 52.00 | 50.00 | |
4 | Nanotechnology, Science and Applications | journal | 0.848 Q1 | 35 | 5 | 26 | 302 | 170 | 26 | 5.53 | 60.40 | 61.11 | |
5 | Diabetes, Metabolic Syndrome and Obesity | journal | 0.835 Q2 | 64 | 368 | 1259 | 16211 | 4174 | 1243 | 2.88 | 44.05 | 48.16 | |
6 | Journal of Experimental Pharmacology | journal | 0.778 Q2 | 23 | 41 | 153 | 1868 | 578 | 152 | 3.76 | 45.56 | 30.72 | |
7 | Therapeutics and Clinical Risk Management | journal | 0.752 Q1 | 70 | 90 | 357 | 4189 | 986 | 352 | 2.35 | 46.54 | 38.52 | |
8 | Infection and Drug Resistance | journal | 0.743 Q2 | 65 | 698 | 1733 | 27973 | 5784 | 1701 | 2.87 | 40.08 | 44.32 | |
9 | Patient Preference and Adherence | journal | 0.647 Q1 | 67 | 301 | 777 | 12103 | 1891 | 764 | 2.18 | 40.21 | 52.17 | |
10 | Drug, Healthcare and Patient Safety | journal | 0.571 Q3 | 30 | 16 | 76 | 757 | 205 | 76 | 2.52 | 47.31 | 38.71 | |
11 | Open Access Journal of Clinical Trials | journal | 0.561 Q1 | 15 | 1 | 15 | 54 | 31 | 14 | 1.11 | 54.00 | 37.50 | |
12 | Pharmacogenomics and Personalized Medicine | journal | 0.508 Q3 | 37 | 95 | 303 | 4240 | 582 | 301 | 1.94 | 44.63 | 42.08 | |
13 | Fluoride - Quarterly Reports | journal | 0.178 Q4 | 51 | 45 | 74 | 1579 | 45 | 65 | 0.49 | 35.09 | 56.05 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®